Trials / Completed
CompletedNCT05449717
Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
A Prospective Cohort Study on the Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis After Treatment for Primary Visceral Leishmaniasis in South Sudan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Epicentre · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis.
Detailed description
This prospective, observational cohort study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis from a hospital in Lankien, South Sudan.
Conditions
Timeline
- Start date
- 2022-05-31
- Primary completion
- 2025-04-11
- Completion
- 2025-04-11
- First posted
- 2022-07-08
- Last updated
- 2025-04-24
Locations
1 site across 1 country: South Sudan
Source: ClinicalTrials.gov record NCT05449717. Inclusion in this directory is not an endorsement.